NCT07450131 · University Hospitals Cleveland Medical Center
POP SINGER Pilot Study
(POP SINGER 1)
What this study is about
Conduct a single-treatment group$1 pilot study (N = 24) to examine the feasibility and acceptability of the hybrid (i.e., half in-person, half online) POPSINGER group Music Therapy (MT) intervention.
View original scientific description
Conduct a single-arm pilot study (N = 24) to examine the feasibility and acceptability of the hybrid (i.e., half in-person, half online) POPSINGER group Music Therapy (MT) intervention.
Who can participate
This study lists these criteria on ClinicalTrials.gov. A study coordinator reviews eligibility during screening — this page does not determine whether you qualify.
Inclusion criteria
- Adults age 18 and older
- Reporting pain on most days per month for a duration of ≥3 months
- Independently ambulatory
- Willing to participate in full scope of program
- Access to internet, active email address, \& laptop, tablet, and/or PC with videoconferencing capabilities
- Have reliable access to a mobile device with an active data plan at home and is comfortable accessing the internet and their email with this device
- Able to read and understand English
Exclusion criteria
- Significant hearing and/or visual impairment
- Have had a major surgery (e.g., spine surgery, joint replacement) within the past 6 months
- Have a planned surgery within the next 6 months at the time of enrollment
- Unable to independently provide consent (i.e., no proxy consent)
- Active suicidal ideation
- Severe psychological comorbidity (e.g., psychosis, schizophrenia) that would prevent patient from engaging fully in intervention
- Receiving active cancer treatment
- Diagnosed with medical condition likely to be terminal within 24 weeks
- Active substance abuse diagnosis in EHR
- Currently receiving music therapy from a professional music therapist
Where
- Cleveland, Ohio
Frequently asked questions
What is a clinical trial?
A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.
Is it safe to participate?
Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.
Will I be compensated?
Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.
Will I receive a placebo instead of treatment?
When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.
Can I leave a trial if I change my mind?
Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.
How long does a clinical trial last?
Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.
Data: ClinicalTrials.gov · synced Apr 21, 2026 · Source of record for eligibility and locations